Abstract
Background: Exosomes are cytoplasm containing vesicles released by many cells that can be found in several biological fluids including urine. Urinary exosomes are released from every segment of the nephron, are detectable in urine, constitutively contain RNA (small RNAs and mRNAs) and harbor unique subset of proteins, reflecting their cellular source.
Methods: With the aim of establishing the optimal protocol for high throughput analysis of exosomal miRNAs, we compared three different urinary exosomes isolation methods and six RNA extraction techniques. Exosomal RNA yield, size and quality were assessed respectively by specific staining with fluorescent dye, capillary electrophoresis and analysis of spectrophotometric parameters. MiRNAs detection and abundance was determined by RT-qPCR.
Results: Among the exosomes isolation methods, Ultrafiltration resulted to be the most suited. The highest exosomal RNA yield quantified by RiboGreen® staining was obtained with the combination of TRI Reagent™ with miRNeasy®, followed by TRI Reagent™, SeraMir™, miRCURY™, mirVana™ and miRNeasy®; but after a multivariate analysis, SeraMir™ scored as the method of choice in terms of miRNA yield, purity and RT-qPCR miRNAs quantification accuracy. Storage conditions were also analyzed, showing that the relative abundance of urinary exosomal miRNAs is not influenced by urine freezing.
Conclusions: The selection of appropriate urinary exosomal miRNA isolation method was dependent on various validation results. Ultrafiltration in combination with SeraMir™ exoRNA columns represents the optimal procedure for a rapid, cost-effective and efficient purification of miRNAs from urinary exosomes, perfectly suited for further applicative research in the field of miRNAs in kidney physiology and pathology.
This study was supported by research grants of the Ministero dell’Istruzione dell’Università e della Ricerca (PRIN projects 200999KRFW_004), the University of Verona (Joint Project_2010 grant), Fondazione Cariverona (“Verona nano-medicine initiative” project).
Conflict of interest statement
Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article. Research funding played no role in the study design, in the collection, analysis, and interpretation of data, in the writing of the report or in the decision to submit the report for publication.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
References
1. Stoorvogel W, Kleijmeer MJ, Geuze HJ, Raposo G. The biogenesis and functions of exosomes. Traffic 2002;3:321–30.10.1034/j.1600-0854.2002.30502.xSearch in Google Scholar PubMed
2. Schorey JS, Bhatnagar S. Exosome function: from tumor immunology to pathogen biology. Traffic 2008;9:871–81.10.1111/j.1600-0854.2008.00734.xSearch in Google Scholar PubMed PubMed Central
3. Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 2002;360:295–305.10.1016/S0140-6736(02)09552-1Search in Google Scholar PubMed
4. Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002;2:569–79.10.1038/nri855Search in Google Scholar PubMed
5. Hendrix A, Westbroek W, Bracke M, De Wever O. An ex(o)citing machinery for invasive tumor growth. Cancer Res 2010;70:9533–7.10.1158/0008-5472.CAN-10-3248Search in Google Scholar PubMed
6. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biol 2007;9:654–9.10.1038/ncb1596Search in Google Scholar PubMed
7. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008;10:1470–6.10.1038/ncb1800Search in Google Scholar PubMed PubMed Central
8. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008;110:13–21.10.1016/j.ygyno.2008.04.033Search in Google Scholar PubMed
9. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA 2004;101:13368–73.10.1073/pnas.0403453101Search in Google Scholar PubMed PubMed Central
10. Zhou H, Yuen PS, Pisitkun T, Gonzales PA, Yasuda H, Dear JW, et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int 2006;69:1471–6.10.1038/sj.ki.5000273Search in Google Scholar PubMed PubMed Central
11. Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, Kleta R, et al. Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol 2009;20:363–79.10.1681/ASN.2008040406Search in Google Scholar PubMed PubMed Central
12. Van Balkom BW, Pisitkun T, Verhaar MC, Knepper MA. Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases. Kidney Int 2011;80:1138–45.10.1038/ki.2011.292Search in Google Scholar PubMed PubMed Central
13. Ambros V. The functions of animal microRNAs. Nature 2004;431:350–5.10.1038/nature02871Search in Google Scholar PubMed
14. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215–33.10.1016/j.cell.2009.01.002Search in Google Scholar PubMed PubMed Central
15. Liu N, Olson EN. MicroRNA regulatory networks in cardiovascular development. Dev Cell 2010;18:510–25.10.1016/j.devcel.2010.03.010Search in Google Scholar PubMed PubMed Central
16. Saal S, Harvey SJ. MicroRNAs and the kidney: coming of age. Curr Opin Nephrol Hypertens 2009;18:317–23.10.1097/MNH.0b013e32832c9da2Search in Google Scholar PubMed
17. Bhatt K, Mi QS, Dong Z. microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am J Physiol Renal Physiol 2011;300:F602–10.10.1152/ajprenal.00727.2010Search in Google Scholar PubMed PubMed Central
18. Chandrasekaran K, Karolina DS, Sepramaniam S, Armugam A, Wintour EM, Bertram JF, et al. Role of microRNAs in kidney homeostasis and disease. Kidney Int 2012;81:617–27.10.1038/ki.2011.448Search in Google Scholar PubMed
19. Cheng Y, Wang X, Yang J, Duan X, Yao Y, Shi X, et al. A translational study of urine miRNAs in acute myocardial infarction. J Mol Cell Cardiol 2012;53:668–76.10.1016/j.yjmcc.2012.08.010Search in Google Scholar PubMed PubMed Central
20. Hanke M, Hoefig K, Merz H, Feller AC, Kausch I, Jocham D, et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 2010;28:655–61.10.1016/j.urolonc.2009.01.027Search in Google Scholar PubMed
21. Melkonyan HS, Feaver WJ, Meyer E, Scheinker V, Shekhtman EM, Xin Z, et al. Transrenal nucleic acids: from proof of principle to clinical tests. Ann N Y Acad Sci 2008;1137:73–81.10.1196/annals.1448.015Search in Google Scholar PubMed
22. Miranda KC, Bond DT, McKee M, Skog J, Paunescu TG, Da Silva N, et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int 2010;78:191–9.10.1038/ki.2010.106Search in Google Scholar PubMed PubMed Central
23. Keller S, Ridinger J, Rupp AK, Janssen JW, Altevogt P. Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med 2011;9:86.10.1186/1479-5876-9-86Search in Google Scholar PubMed PubMed Central
24. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNA spectrum in 12 body fluids. Clin Chem 2010;56:1733–41.10.1373/clinchem.2010.147405Search in Google Scholar PubMed PubMed Central
25. Alvarez ML, Khosroheidari M, Kanchi Ravi R, DiStefano JK. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int 2012;82:1024–32.10.1038/ki.2012.256Search in Google Scholar PubMed
26. Bryant RJ, Pawlowski T, Catto JW, Marsden G, Vessella RL, Rhees B, et al. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer 2012;106:768–74.10.1038/bjc.2011.595Search in Google Scholar PubMed PubMed Central
27. Eldh M, Lotvall J, Malmhall C, Ekstrom K. Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods. Mol Immunol 2012;50:278–86.10.1016/j.molimm.2012.02.001Search in Google Scholar PubMed
28. Olivieri O, Castagna A, Guarini P, Chiecchi L, Sabaini G, Pizzolo F, et al. Urinary prostasin: a candidate marker of epithelial sodium channel activation in humans. Hypertension 2005;46:683–8.10.1161/01.HYP.0000184108.12155.6bSearch in Google Scholar PubMed
29. Cheruvanky A, Zhou H, Pisitkun T, Kopp JB, Knepper MA, Yuen PS, et al. Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. Am J Physiol Renal Physiol 2007;292:F1657–61.10.1152/ajprenal.00434.2006Search in Google Scholar PubMed PubMed Central
30. Gonzales PA, Zhou H, Pisitkun T, Wang NS, Star RA, Knepper MA, et al. Isolation and purification of exosomes in urine. Methods Mol Biol 2010;641:89–99.10.1007/978-1-60761-711-2_6Search in Google Scholar PubMed
31. Taylor DD, Zacharias W, Gercel-Taylor C. Exosome isolation for proteomic analyses and RNA profiling. Methods Mol Biol 2011;728:235–46.10.1007/978-1-61779-068-3_15Search in Google Scholar PubMed
32. Rood IM, Deegens JK, Merchant ML, Tamboer WP, Wilkey DW, Wetzels JF, et al. Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int 2010;78:810–6.10.1038/ki.2010.262Search in Google Scholar PubMed
33. Fernandez-Llama P, Khositseth S, Gonzales PA, Star RA, Pisitkun T, Knepper MA. Tamm-Horsfall protein and urinary exosome isolation. Kidney Int 2010;77:736–42.10.1038/ki.2009.550Search in Google Scholar PubMed PubMed Central
34. Lasser C, Eldh M, Lotvall J. Isolation and characterization of RNA-containing exosomes. J Vis Exp 2012;59:e3037.10.3791/3037Search in Google Scholar PubMed PubMed Central
35. Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, et al. Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 2009;55:1977–83.10.1373/clinchem.2009.131797Search in Google Scholar PubMed
36. Etheridge A, Lee I, Hood L, Galas D, Wang K. Extracellular microRNA: a new source of biomarkers. Mut Res 2011;717:85–90.10.1016/j.mrfmmm.2011.03.004Search in Google Scholar PubMed PubMed Central
37. Nakajima M, Yokoi T. MicroRNAs from biology to future pharmacotherapy: regulation of cytochrome P450s and nuclear receptors. Pharmacol Ther 2011;131:330–7.10.1016/j.pharmthera.2011.04.009Search in Google Scholar PubMed
38. Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 2012;1820:940–8.10.1016/j.bbagen.2012.03.017Search in Google Scholar PubMed
39. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids – the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011;8:467–77.10.1038/nrclinonc.2011.76Search in Google Scholar PubMed PubMed Central
40. Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010;50:298–301.10.1016/j.ymeth.2010.01.032Search in Google Scholar PubMed PubMed Central
©2014 by Walter de Gruyter Berlin Boston
